Olfactory Neuroblastomas: An Experience of 24 Years

Table 2

Patient characteristics, treatment modalities, and outcome.

Patient no.	Age	Sex	Grade	Kadish stage	Treatment	Reccurence	Time to reccurence (months)	Metastases	Treatment reccurence	Overall Survival (months)	Outcome
1	33	F	G 4	B	S + RT	Local	6.3	No distant metastasis	S + RT	67.8	DLD
2	40	M	G 4	C	RT + CTX	Distant site	5.2	Spinal cord + menengeal	RT	7.4	DMD
3	47	M	G 4	B	S + RT	Distant site	7.7	Brain	CTX + RT	9.3	DMD
4	30	F	G 2	A	RT + CTX	Local	70	No distant metastasis	CTX	90.1	Alive
5	63	M	Unk.	C	RT	Distant site	10.8	Lung	CTX	28.8	DMD
6	54	M	G2	A	S	Local	124	No distant metastasis	S + RT	152	DLD
7	17	M	G 4	C	S + RT	Distant site		Cervical lymph node + Menengeal + Bone marrow	RT	11.8	DMD
8	46	M	G 2	C	S + RT	Neck	23.6	Cervical lymph node	S + RT	99.4	DMD
9	67	F	Unk.	C	S + RT	Distant site		Brain + Bone marrow	RT + CTX	9.2	DMD
10	62	M	Unk.	C	RT	Local	7.3	No distant metastasis	RT + CTX	31	DLD
11	34	M	G 4	C	RT + CTX + S	Distant site	13.1	Brain	CTX + RT	9.7	DMD
12	33	M	G 3	B	RT + CTX + S	Local	12	No distant metastasis	RT	22.2	DLD
13	50	F	G 4	C	RT + CTX + S	Distant site	14.4	Spinal cord	CTX + RT	23.7	DMD
14	38	M	G 4	C	CTX	Distant site	8.5	Brain + Bone marrow	CTX + RT	20.7	DMD
15	45	M	G 4	C	S	Distant site		Brain	PC	3.4	DMD
16	40	F	G 4	C	S	Distant site		Brain	PC	3	DMD
17	68	F	G 3	B	S + RT	Distant site	66.5	Bone	RT	87	Alive
18	62	M	G 4	B	S	Local	11.4	No distant metastasis	S + RT	25.1	DLD
19	42	M	G 1	A	S + RT	No recurrence				72	Alive

CTX: chemotherapy; RT: radiotherapy; S: surgery; PC: palliative care; DLD: died of local disease; DMD: died of metastatic disease; G: grade; Unk: unknown.